When.com Web Search

  1. Ads

    related to: carbidopa levodopa for parkinson's disease treatment centers tennessee open

Search results

  1. Results From The WOW.Com Content Network
  2. Carbidopa/levodopa - Wikipedia

    en.wikipedia.org/wiki/Carbidopa/levodopa

    Carbidopa/levodopa, also known as levocarb and co-careldopa, is the combination of the two medications carbidopa and levodopa. [6] It is primarily used to manage the symptoms of Parkinson's disease , but it does not slow down the disease or stop it from getting worse. [ 6 ]

  3. Aromatic L-amino acid decarboxylase inhibitor - Wikipedia

    en.wikipedia.org/wiki/Aromatic_L-amino_acid_de...

    Peripherally selective DDCIs incapable of crossing the protective blood–brain barrier (BBB) are used in augmentation of L-DOPA (levodopa) in the treatment of Parkinson's disease (PD) to block the conversion of L-DOPA into dopamine outside the brain, for the purpose of reducing adverse side effects. [3]

  4. Category:Antiparkinsonian agents - Wikipedia

    en.wikipedia.org/wiki/Category:Antiparkinsonian...

    These agents are used to treat Parkinson's disease. Anti-Parkinsonian Drugs include: Anticholinergic Agents; COMT Inhibitors; Dopamine Agonists; Levodopa; MAO-B Inhibitors

  5. Management of Parkinson's disease - Wikipedia

    en.wikipedia.org/wiki/Management_of_Parkinson's...

    In the management of Parkinson's disease, due to the chronic nature of Parkinson's disease (PD), a broad-based program is needed that includes patient and family education, support-group services, general wellness maintenance, exercise, and nutrition. At present, no cure for the disease is known, but medications or surgery can provide relief ...

  6. Carbidopa - Wikipedia

    en.wikipedia.org/wiki/Carbidopa

    Carbidopa (Lodosyn) is a drug given to people with Parkinson's disease in order to inhibit peripheral metabolism of levodopa.This property is significant in that it allows a greater proportion of administered levodopa to cross the blood–brain barrier for central nervous system effect, instead of being peripherally metabolised into substances unable to cross said barrier.

  7. Catechol-O-methyltransferase inhibitor - Wikipedia

    en.wikipedia.org/wiki/Catechol-O-methyltransfer...

    COMT inhibitors are indicated for the treatment of Parkinson's disease in combination with levodopa and an aromatic L-amino acid decarboxylase inhibitor (e.g. carbidopa or benserazide). The therapeutic benefit of using a COMT inhibitor is based on its ability to prevent the methylation of levodopa to 3- O -methyldopa , thus increasing the ...

  1. Related searches carbidopa levodopa for parkinson's disease treatment centers tennessee open

    parkinson's treatment wikipediaparkinson's cure